The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 120 participants.
Also called NCT01123161
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01123161
-
- Other papers using this trial's data
- Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Switzerland
- Registry status
- Terminated
Technical summary
Registry record NCT01123161. Randomized; single masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2015-01 (actual). Results posted on 2017-04-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
- Acronym
- ICTuS2/3
- Condition
- Stroke, Acute
- Intervention (Device)
- hypothermia and anti-shivering treatment
- Intervention (Drug)
- Group1: IV t-PA and normothermia
- Lead sponsor
- University of California, San Diego
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator
- The University of Texas Health Science Center, Houston
Record details
- Record id
cardio:ct-nct01123161- Content hash
a38a6e9bd9c450667e6f0ca0632503eb4ed19e648c3c00474ab48c04b0c92b57